Diagnostic usefulness of enzyme-linked immunospot assay for interferon-gamma for tuberculosis in cancer patients.

MLA

Lai, Chih-Cheng, et al. “Diagnostic Usefulness of Enzyme-Linked Immunospot Assay for Interferon-Gamma for Tuberculosis in Cancer Patients.” Scandinavian Journal of Infectious Diseases, vol. 42, no. 11/12, Nov. 2010, pp. 851–56. EBSCOhost, https://doi.org/10.3109/00365548.2010.498022.

APA

Lai, C.-C., Tan, C.-K., Lin, S.-H., Liu, W.-L., Liao, C.-H., Wang, C.-Y., Wang, J.-Y., Huang, Y.-T., Lin, H.-I., & Hsueh, P.-R. (2010). Diagnostic usefulness of enzyme-linked immunospot assay for interferon-gamma for tuberculosis in cancer patients. Scandinavian Journal of Infectious Diseases, 42(11/12), 851–856. https://doi.org/10.3109/00365548.2010.498022

Chicago

Lai, Chih-Cheng, Che-Kim Tan, Sheng-Hsiang Lin, Wen-Lun Liu, Chun-Hsing Liao, Cheng-Yi Wang, Jen-Yu Wang, Yu-Tsung Huang, Hen-I Lin, and Po-Ren Hsueh. 2010. “Diagnostic Usefulness of Enzyme-Linked Immunospot Assay for Interferon-Gamma for Tuberculosis in Cancer Patients.” Scandinavian Journal of Infectious Diseases 42 (11/12): 851–56. doi:10.3109/00365548.2010.498022.